Lumena Pharmaceuticals Inc
1 known investors
Mirum Pharmaceuticals develops and markets therapies for rare diseases, designing treatment programs with regulatory strategy and patient access in mind. The company operates a global portfolio of approved products and investigational medicines targeting high-need patient populations.